Maternal SSRI use during pregnancy may be associated with altered brain development in children; however, this study cannot fully rule out contributions of confounding genetic and enviromental factors.
This study provides reassuring data on the use of mirtazapine during pregnancy, demonstrating no association between exposure and risk of major malformations or pregnancy loss.
This hotline will offer a range of support, including brief interventions, referrals to both community-based and telehealth providers as needed.
Data from an ongoing pregnancy registry offers reassurance that benzodiazepines do not appear to have major teratogenic effects.
May 4, 2022 is World Maternal Mental Health Day, coming together to increase awareness of perinatal mood and anxiety disorders.
TMS in pregnancy and the postpartum period appears to be a promising treatment option with no reports of adverse obstetric outcomes or congenital malformations.
There is evidence that depression itself can increase risk for hypertension and preeclampsia. Future studies will help to clarify the complex interaction between depression, SSRI treatment and pre-eclampsia.
Last month, the Alliance for Innovation on Maternal Health (AIM) launched a new Patient Safety Bundle addressing perinatal mental health conditions. The current revision addresses gaps in the safety bundle previously released in 2016. Patient [...]
Eating disorders are common among women during the childbearing years; however, information on eating disorders in pregnant and postpartum women is relatively sparse.
This very helpful list from Wendy Davis, PhD, Executive Director of Postpartum Support International, describes what the various emergency services can provide.
